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Background: The human opportunistic pathogen, Pseudomonas aeruginosa (P. aeruginosa) carries the highest
case fatality rate of all gram-negative infections. Unfortunately, antimicrobial therapy has not been demonstrated
to improve clinical outcome and the emergence of multidrug resistant P. aeruginosa has become a major concern
in the hospital setting. Fever and diarrhea are the two most common initial symptoms in P. aeruginosa sepsis in
previously healthy infants and children. This implies that intestinal epithelial cells in first contact with the pathogen
may play an important role in innate immunity to P. aeruginosa infection. Human beta–defensins-2 (hBD-2) and
interleukin-8 (IL-8) are crucial for host defense at mucosa but IL-8 may give rise to characteristic pathology of colitis.
Results: Pseudomonas aeruginosa strain PAO1 was used to infect SW480, an intestinal epithelial cell. IL-8 and hBD-2
mRNA expression and protein secretion were then assessed in SW480 cells using RT-PCR and enzyme-linked
immunosorbent assay (ELISA), respectively. Intracellular signaling pathways and nucleotide-binding oligomerization
domain (NOD) 1 protein expression were analyzed by Western blot in SW480 cells in the presence or absence of
inhibitors or transfected with siRNA.
We demonstrate that prolonged infection by P. aeruginosa results in suppression of IL-8 but enhancement of
hBD-2, either protein secretion and mRNA expression, in SW480 cells. Inhibitors of ERK suppressed but inhibitor of
PI3K enhanced P. aeruginosa-induced IL-8 mRNA expression in SW480 cells while both signaling had no effect on
P. aeruginosa-induced hBD-2 expression in SW480 cells. On the other hand, NOD 1 was illustrated to get involved in
P. aeruginosa-induced hBD-2 mRNA expression and protein production in SW480 cells.
Conclusions: The P. aeruginosa-induced antimicrobial peptide in IECs continuously protect the host against
prolonged infection, while modulation of proinflammatory responses prevents the host from the detrimental effects
of overwhelming inflammation. Thus, P. aeruginosa-induced innate immunity in IECs represents a host protective
mechanism, which may provide new insight into the pathogenesis of inflammatory bowel diseases.
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The human opportunistic pathogen, Pseudomonas
aeruginosa (P. aeruginosa), is a major cause of infection-
related mortality among critically ill patients, and carries
the highest case fatality rate of all gram-negative infections
[1]. Although rare, P. aeruginosa bacteremia is often
rapidly progressive and can occur with a high mortality
rate in previously healthy patients [2,3], even receivingCorrespondence: huang817@cgmh.org.tw
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pediatric study of Pseudomonas bacteremia, antimicrobial
susceptibility was not identified as a prognostic factor [4].
P. aeruginosa is not only difficult to treat but also exhibits
remarkable ability to acquire resistance to these agents
[5]. Overall, resistance rates are on the increase. Multidrug
resistance is frequent, and clinical isolates resistant to
virtually all anti-pseudomonal agents are increasingly
being reported. Therefore, effective immunotherapy may
be a useful alternative therapy administered either alone
or in combination with antibiotic chemotherapy.his is an Open Access article distributed under the terms of the Creative
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P. aeruginosa in previously healthy infants and children
[2], fever and diarrhea were the two most common initial
symptoms. P. aeruginosa was also isolated in 43% of fecal
specimens. This implied that intestinal epithelial cell first
contacting the pathogen may play an important role on
innate immunity to P. aeruginosa infection. In addition to
serving as a protective barrier, the epithelium plays an
active role in the intestinal immune response through
its secretion of inflammatory cytokines, chemokines,
and antimicrobial peptides [6,7]. Antimicrobial peptides,
such as human β–defensins-2 (hBD-2), are crucial for host
defense at mucosal surfaces while chemokines, such
as interleukin-8 (IL-8), recruit neutrophils from the
circulation into the subepithelial region to defend against
the invasion of bacteria, but give rise to characteristic
pathology of colitis [8].
Two main families of pattern-recognition receptors
involved in innate immune detection have been discovered
in human beings. Toll-like receptors (TLRs) are transmem-
branous molecules [9] and cytosolic Nucleotide-binding
oligomerization domains (NODs) [10] are seen as the
intracellular counterpart of the TLRs. Both play essential
roles in the clearance of P. aeruginosa [11]. Shedding of
flagellin, recognized by TLR5, from P. aeruginosa provokes
hBD-2 and IL-8 response in human keratinocytes [12].
Intestinal epithelial cells (IECs) are generally hyporespon-
sive to extracellular bacterial products, especially TLR2 and
TLR4 ligands [13]. The unresponsiveness of IECs to TLR
signals sets the stage for the function of NOD proteins as
important sensors for the detection of bacteria invading the
epithelium [14]. Autophagy plays an essential role in the
clearance of P. aeruginosa by alveolar macrophages. Two
groups of investigators [15,16] have demonstrated that
NOD1 and NOD2 are critical for the autophagic response
to invasive bacteria because they recruit ATG16L1 to
bacterial entry sites at the plasma membrane. Several
studies have implicated NOD1-dependent NF-κB activation
in the induction of β-defensins and chemokines expression
in response to H. pylori [17] and S. flexneri infection [18].
Moreover, a recent study showed that NOD2 is essential in
the enhancement of IL-8 induced by S. aureus through
activation of c-jun NH2-terminal kinase (JNK) pathway
and upregulation of COX2 [19]. The cooperation of TLR5
and NOD2 in IECs regulates inflammatory response to
Salmonella infection [20].
Therefore, we aim to investigate the intestinal epithelial
IL-8 and hBD-2 expression in P. aeruginosa-infected IECs
and the downstream signaling pathways of TLRs or NODs
involved in the effects. Up to now, the innate immunity of
IECs to P. aeruginosa infection has been completely
unknown. We have studied the inflammatory responses in
P. aeruginosa-infected IECs, and for the first time reveal
the differential regulation of P. aeruginosa-induced IL-8and hBD-2 in IECs via PI3K/Akt signal and NOD1
protein respectively. This observation could provide
useful information for further understanding of the
innate immunity in mucosal P. aeruginosa infection.
Methods
Cell culture and infection
SW480 and Caco-2 cells (ATCC, Rockville, MD), trans-
formed human colonic epithelial cell lines, were grown in
Dulbecco modified Eagle medium (DMEM) supplemented
with 10% heat-inactivated fetal calf serum, 100 units/ml
penicillin, 100 μg/ml streptomycin sulfate, and 20 mM
HEPES (Sigma) in a 5% CO2 atmosphere at 37°C. Passage
10–30 will be used for all experiments. For stimulation
experiments, cells were seeded in 12-well tissue culture
plates (4 cm2/well; BD Biosciences) and used at 60–80%
confluence.
Reagents
The PI3K inhibitors, wortmannin and LY294002, and the
mitogen-activated protein (MAP) kinase ERK inhibitor,
PD98059 were obtained from Calbiochem (San Diego, CA)
and stock solutions made in dimethylsulfoxide (DMSO).
Standard laboratory reagents were from Sigma (St. Louis,
MO, USA) or Fisher Scientific (Pittsburgh, PA, USA).
Bacterial strain
P. aeruginosa strain PAO1 is a well-characterized laboratory
strain. It is grown in tryptic soy broth (Difco Laboratories,
Detroit, MI) supplemented with 10 μg/ml kanamycin for
6 h until the optical density at 600 nm is 0.5 or the concen-
tration is about 1 × 108 CFU/ml. The bacteria is collected
by centrifugation at 3,000 rpm for 10 min, washed twice by
resuspension in sterile phosphate-buffered saline (PBS)
(GIBCO, Grand Island, NY), and finally suspended at the
desired dilution in PBS. Cultured cells were infected at a
multiplicity of infection (MOI) of 10 for indicated times.
Cytokine assays
IL-8 ELISA
After treatment, the medium was aspirated at the end of
the infection period, from control or infected cells, cleared
of any P. aeruginosa or cellular debris by centrifugation
(5 min, 1,000 × g), then stored at —20°C until use. The
supernatant medium was collected and IL-8 concentra-
tions determined by enzyme-linked immunosorbent assay
(ELISA) as described in detail earlier [20,21].
hBD-2 ELISA
After treatment or infection, the supernatant medium
of the cultured cells was collected and hBD-2 concen-
trations determined by enzyme-linked immunosorbent
assay (ELISA) as manufacturer’s instructions with some
modification. Briefly, 96-well immunoplates were coated
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NJ). After blocking and washing, 100 μl/well of cell
culture supernatants and serial dilutions of standard
hBD-2 in cell culture medium were incubated for
30 min at room temperature. Subsequently, wells were
incubated with biotinylated goat anti-hBD-2 antibody
(Cell Concepts), filled with 50 μl/well of Streptavidin-POD
(Roche Diagnostics) and developed by ABTS (Roche
Diagnostics). Absorbance is measured at 405 nm with
a multichannel photometer (Sunrise; Tecan, Crailsheim,
Germany). Because of variations in baseline hBD-2
production, the results are expressed as “fold increase”,
representing the normalized hBD-2 produced by infected
monolayers divided by the normalized hBD-2 produced
by control, uninfected cells.
Protein extraction
Cytosolic and membranous extracts from untreated and
treated SW480 cells were prepared as manufacturer’s
instructions with slight modifications [21,22]. Protein
concentrations in cell fractions were determined using
a Bio-Rad assay kit.
Western blotting
Equal amounts of total protein were separated by
SDS-PAGE and then transferred to nitrocellulose mem-
branes by semi-dry blotting as previously described [23,24].
After blocking the membranes with 5% non-fat dry milk,
they were probed with antibodies to either phosphorylated
p38, JNK, Akt (Cell Signaling, Beverly, MA), phosphory-
lated ERK (Santa Cruz Biotechnology, Santa Cruz, CA),
phosphorylated IκB (New England BioLabs, Beverly, MA),
anti-MyD88, ATG16L1, Beclin-1, Atg5, rabbit anti-LC3
(Cell Signaling, Beverly, MA), or anti-NOD1 and NOD2
(Cayman Chemical, Ann Arbor, MI), and then developed
with horseradish peroxidase-conjugated second antibodies
(Zymed Laboratories, San Francisco, CA) and enhanced
chemiluminescence (Pierce Chemical Co., Rockford, IL).
Appropriate exposures to X-ray film were made, and
the filters then stripped and re-probed with antibodies
to GAPDH (Santa Cruz Biotechnology, Santa Cruz,
CA) as appropriate.
Real-time PCR for mRNA assay
Total RNA was prepared from control or infected cells
with the Trizol reagent (Invitrogen Corporation, Carlsbad,
CA), following the manufacturer’s directions. The RNA
was reverse-transcribed with random hexamers using the
GeneAmp kit (Roche, Nutley, NJ) as described in detail
earlier [20,21,23,24]. Real-time reverse transcription-PCR
analyses were performed in a fluorescence temperature
cycler (LightCycler; Roche Diagnostics) as described previ-
ously [20,21]. The following primers were used: IL-8, 5′-
AAACCACCGGAAGGAACCAT-3′ (forward primer)and 5′-GCCAGCTTGGAAGTCATGT-3′ (reverse pri-
mer); hBD-2, 5′-ATCAGCCATGAGGGTCTTGT-3′ (for-
ward primer) and 5′-GAGACCACAGGTGCCAATTT-3′
(reverse primer); or glyceraldehyde-3-phosphate de-
hydrogenase, 5′-CCAGCCGAGCCACATCGCTC-3′ (for-
ward primer) and 5′-ATGAGCCCCAGCCTTCTCCAT-3’.
Standard curves were obtained for each primer set with
serial dilutions of cDNA. All quantifications were nor-
malized to the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase. Relative expression was given as
a ratio between target gene expression and glyceraldehyde-
3-phosphate dehydrogenase expression.
Small-interfering RNA (siRNA) transfection
All transient transfections were carried out in triplicate
using NeoFX reagent (Ambion, Austin, TX) to final
concentration of 20 nM following the manufacturer’s
instructions. The siRNAs used were as follows: NOD1
siRNA and siRNA for the negative control (Invitrogen
Corporation, Carlsbad, CA). All siRNA were tested
and verified as reducing expression by >80% protein
reduction in SW480 cells by immunoblot analysis or
reducing expression of >50% of mRNA by real-time
PCR when appropriate Ab was not available, as in our pre-
vious work [20]. For the SW480 cells, 20nM of each siRNA
was transfected 48–96 h before P. aeruginosa infection.
Statistical analysis
All above experiments were carried out at least three
times with similar results. Statistical significance was
determined using the Student’s t-test.
Results
Prolonged infection by P. aeruginosa resulted in
suppression of IL-8 but enhancement of hBD-2 protein
secretion
The cultured cells were uninfected (control) or infected
by P. aeruginosa for indicated times. Supernatant of
cultured cells was analyzed by ELISA for IL-8 and
hBD-2 secretion. As shown in Figure 1, the production of
IL-8 and hBD-2 followed two distinct time-courses. First,
IL-8 showed a peak after 5 hours and a decline thereafter. A
second, distinct time-course was observed for hBD-2, which
remained elevated 7 hours after P. aeruginosa infection.
Prolonged infection by P. aeruginosa results in
enhancement of IL-8 and hBD-2 mRNA expression in
SW480 cells
We proceeded to examine the effect of P. aeruginosa
infection on IL-8 and hBD-2 mRNA levels. SW480
cells were either uninfected or infected by P. aeruginosa.
Total RNA was prepared, reverse transcribed with random
hexamers, and analyzed by real-time quantitative PCR. As
shown in Figure 2, P. aeruginosa infection induced IL-8
Figure 1 The effect of prolonged infection by P. aeruginosa on IL-8 and hBD-2 proteins secretion in SW480 cells. SW480 cells were left
uninfected (CON) or infected with the wild-type P. aeruginosa strain PAO1 for the times indicated. Supernatant was analyzed by ELISA 6 hours
later for IL-8. The amount of IL-8 produced is shown as the fold increase over uninfected control cells. Results are represented as means ± S.E.M.
for at least three determinations from independent experiments. (*p <0.05; # p <0.05).
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GAPDH) after one-hour infection in SW480 cells.
Both IL-8 mRNA and hBD-2 mRNA in SW480 cells
continued to increase after prolonged infection.
The involvement of ERK PI3K/Akt, NF-κB signaling
pathway and NOD1 protein in SW480 cells after
P. aeruginosa infection
To further evaluate which signaling pathway is involved
in P. aeruginosa–induced IL-8 and hBD-2 regulation, we
investigated the downstream signal pathways of TLRs
and autophagy proteins. SW480 cells were uninfected orFigure 2 The effect of prolonged P. aeruginosa infection on IL-8 and
uninfected (CON) infected with the wild-type P. aeruginosa strain PAO1 for
lyzed by real-time quantitative PCR to estimate amounts of IL-8 and hBD-2
to the corresponding amount of GAPDH transcript, is shown as the fold in
± S.E.M. for at least three determinations from independent experiments. (*infected with PAO1. Activation of the ERK JNK, p38,
Akt and IκB, were analyzed in whole cell protein by
Western blot. Western blot data showed that protein
levels of p-ERK were significantly upregulated at 5 and
15 minutes infection, reached peak at 45 min, and
significantly decreased at 120 min when p-Akt and
p-IκB were significantly upregulated (Figure 3), suggesting
the involvement of ERK, Akt and IκB in the downstream
signaling of P. aeruginosa infection. However, the activation
of JNK or p38 had no significant upregulation from 5 to
120 min. Western blot analysis was also applied to evaluate
autophagy proteins expression in P. aeruginosa-infectedhBD-2 mRNA expression in SW480 cells. SW480 cells were left
one to seven hours. Total RNA was prepared after infection and ana-
transcript. The amount of IL-8 and hBD-2 mRNA produced, normalized
crease over uninfected control cells. Results are represented as means
p <0.05; # p <0.05).
Figure 3 The proteins expression of intracellular signaling pathways in P. aeruginosa-infected SW480 cells. SW480 cells were left
uninfected (CON), or infected with wild-type P. aeruginosa strain PAO1 for the times indicated. Activation of the ERK, JNK, p38, Akt and IκB were
analyzed in whole cell protein by immunoblotting with antibodies to phosphorylated (p) ERK, JNK, p38, Akt and IκB. The results shown are representative
of three separate experiments. GAPDH worked as a normalization of cytosolic protein.
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NOD1 continuously increased after prolonged infection by
P. aeruginosa, while other autophagy proteins (e.g. NOD2,
Beclin1 or Atg5) had the same band density even
after prolonged infection (Figure 4). It suggested the
involvement of NOD1 in enhanced hBD-2 expression in
SW480 cells after prolonged P. aeruginosa infection.
The involvement of ERK and PI3K/Akt signaling pathway
in negative regulation of IL-8 after prolonged P. aerugi-
nosa infection
Pretreatment with ERK and PI3K inhibitors (PD98059
for ERK and LY294002 for PI3K) (Figure 5A) suppressed
and upregulated P. aeruginosa-induced IL-8 production
in SW480 cells respectively. These data indicated thatFigure 4 The proteins expression of autophagy in P. aeruginosa-infec
aeruginosa for indicated times. The Western blots illustrate the expression o
extracts of SW480 cells infected by P. aeruginosa at indicated times. The res
worked as a normalization of cytosolic protein.ERK-mediated IL-8 production was suppressed via acti-
vation of the PI3K/Akt signaling pathway. We proceeded
to examine the involvement of ERK and Akt in the P.
aeruginosa-induced IL-8 mRNA levels. SW480 cells were
either uninfected or infected by P. aeruginosa for 7 hours
in the absence or presence of PD98059 or LY294002. Total
RNA was prepared, reverse transcribed with random
hexamers, and analyzed by real-time quantitative PCR. As
shown in Figure 5B, P. aeruginosa infection induced IL-8
mRNA expression (normalized to GAPDH) in SW480 cells.
Both inhibitors had no significant effect on P. aeruginosa-
induced IL-8 mRNA expression in SW480 cells, suggesting
that ERK and PI3K/Akt signal pathways were involved in
P. aeruginosa-induced IL-8 immune response by post-
transcriptional or post-translational mechanisms.ted SW480 cells. SW480 cells were uninfected (CON) or infected by P.
f Agt5, Atg16L1, Beclin 1, LC3B, NOD1 and NOD2 proteins in cytosolic
ults shown are representative of three separate experiments. GAPDH
Figure 5 The involvement of ERK and PI3K/Akt signal pathways in P. aeruginosa-induced IL-8 in SW480 cells. (A) Effect of ERK and PI3K
inhibition on P. aeruginosa-induced IL-8 and hBD-2 secretion. SW480 cells were left untreated, or treated with 25 μM PD98059 (PD) and 50 μM
LY294002 (LY) for one hour. They were then infected with the wild-type P. aeruginosa strain PAO1 for 7 hours. Supernatant was analyzed by ELISA
for IL-8 and hBD-2. The amount of IL-8 and hBD-2 produced is shown as the fold increase over uninfected control (CON) cells. (B) Effect of ERK
and PI3K inhibition on P. aeruginosa-induced IL-8 and hBD-2 mRNA. SW480 cells were left untreated, or treated with 25 μM PD98059 (PD) and
50 μM LY294002 (LY). They were then infected with the wild-type P. aeruginosa strain PAO1 for 7 hours. Total RNA was prepared and analyzed by
real-time quantitative PCR to estimate amounts of IL-8 and hBD-2 transcript. The amount of IL-8 and hBD-2 mRNA produced, normalized to the
corresponding amount of GAPDH transcript, is shown as the fold increase over uninfected control (CON) cells. Results are represented as means
± S.E.M. for at least three determinations from independent experiments. (* p <0.05; # p <0.005).
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for ERK and LY294002 for PI3K) had no significant effect
on P. aeruginosa-induced hBD-2 production (Figure 5A)
or mRNA expression (Figure 5B) in SW480 cells.
The involvement of NOD1 in positive regulation of hBD-2
after prolonged P. aeruginosa infection
Based on our observation that the expression of NOD1
protein was upregulated after prolonged P. aeruginosa
infection, we investigated if NOD1 was involved in the
P. aeruginosa-induced hBD-2 expression. We adapted a
siRNA knockdown approach for NOD1. Knockdown of
NOD1 was confirmed by Western blot with specific siRNA
in SW480 cells up to 48 hrs (Figure 6A). siRNA-transfectedSW480 cells were uninfected or infected by P. aeruginosa
PAO1 for 7 hours. Following knockdown of NOD1, we
detected the P. aeruginosa-induced hBD-2 production
(Figure 6B) and mRNA expression (Figure 6C) in SW480
cells was diminished in NOD1-silenced cells, but not in
control siRNA-silenced cells. It suggested NOD1 was
involved in the enhanced hBD-2 expression in SW480
cells by prolonged P. aeruginosa infection.
It is a general phenomenon in Caco-2 intestinal epithelial
cell lines
To determine whether the above finding was a general
phenomenon among different intestinal epithelial cell
lines, the same experiments were undertaken in Caco-2
Figure 6 The involvement of NOD1 in P. aeruginosa-induced hBD-2 in SW480 cells. SW480 cells were transfected with control siRNA and
NOD1 siRNA (siRNA = non-target control siRNA; siNOD1 = siRNA to NOD1) for 48 hours. The transfected cells were left uninfected or infected by P.
aeruginosa PAO1 for 7 hours. (A) Western blots probed with antibodies against NOD1 and GAPDH confirm knockdown of NOD1. (B) Supernatant
was analyzed by ELISA for secreted IL-8 and hBD-2 protein in SW480 cells. The amount of IL-8 or hBD-2 produced is shown as the fold increase over
control cells. (C) After infection, total RNA was extracted from the cells and analyzed byReal-time PCR, as described in Materials and Methods. Results are
represented as means ± S.E.M. for at least three determinations from independent experiments. An asterisk indicates a significant difference (p <0.05).
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itors and infected with wild-type P. aeruginosa PAO1,
using the same experiments as above. The supernatants
were analyzed for proteins secretion in Caco-2 cells after
treatment of inhibitors or siRNA. The proteins extractedfrom the cells were analyzed for signaling pathways involved
in the regulation. Similar to SW480 cells, we have seen the
same results in Caco-2 cells in response to infection
(Additional file 1: Figure S1, Additional file 2: Figure S2,
Additional file 3: Figure S3 and Additional file 4: Figure S4).
Huang BMC Microbiology 2014, 14:275 Page 8 of 10
http://www.biomedcentral.com/1471-2180/14/275Discussion
While the expression of antimicrobial molecules in epi-
thelial cells has been shown as a key to control infection,
modulation of proinflammatory responses prevents
the cells from the detrimental effects of overwhelming
inflammation. In several models of bacterial infection in
mice, maximum KC (murine IL-8) expression that recruits
and activates neutrophils occurs in the first hours, resulting
in enhanced clearance of bacteria after Pseudomonas
challenge [25]. NF-kappa B is a central regulator of the
intestinal epithelial cell innate immune response induced by
infection with enteroinvasive bacteria [26]. Phosphorylation
of IκB (Figure 3), inhibitor of NF-κB, is targeted for
proteasome-dependent degradation, leading to transloca-
tion of NF-κB to the nucleus and transactivation of NF-κB
target genes, giving rise to IL-8 and hBD-2 mRNA expres-
sion (Figure 2). However, prolonged production of IL-8 will
cause tissue damage. The massive influx of neutrophils into
Pseudomonas-infected sites is stimulated by an excessive
production and release of inflammatory mediators, the
most important of which include prolonged and sustained
expression of IL-8 [27-29]. The accumulation of neutro-
phils, a hallmark of inflammation, in turn contributes to
tissue destruction [30], particularly at the early stage of P.
aeruginosa colonization. Consequently, translocation of
bacteria and absorption of endotoxins may have profound
systemic effects and may result in bacteremia, as well as
endotoxemia. Likewise, intensive mucosal injury by
massive influx of neutrophils may result in translocation of
P aeruginosa into blood stream and subsequent sepsis.
This can also explain why fever and diarrhea are the two
most common initial symptoms in P. aeruginosa sepsis in
previously healthy infants and children [2].
Substantial evidence has shown that PI3K/Akt activation
promotes the internalization of PA strains PAO1 and PAK
by epithelial cells [31], and suppresses a proinflammatory
response through negatively regulating TLR signaling [32].
Based on our observation that PI3K/Akt pathway plays an
anti-inflammatory role, decreasing IL-8 production on
Salmonella infection in IECs via interactions with
ERK kinase [24], we demonstrated that inhibition of
PI3K upregulated but inhibition of ERK suppressed P.
aeruginosa-induced IL-8 production in IECs after pro-
longed infection (Figure 5). It suggested that the anti-
inflammatory PI3K/Akt signal pathway was activated at a
late stage to suppress the detrimental effect of IL-8 overex-
pression after prolonged P. aeruginosa infection (Figure 1).
In contrast, PI3K/Akt has no significant effect on hBD-2
expression (Figure 5), which is needed to defend the
cells against Pseudomonas infection continuously.
PI3K/Akt signaling pathway promotes host resistance
against P. aeruginosa infection by suppressing corneal
inflammation and perforation in mice [33]. Inhibition of
PI3K resulted in worsened disease after P aeruginosacorneal infection. This observation is consistent with some
studies showing that intraperitoneal injection with
wortmannin increased serum cytokines levels and led
to susceptibility to sepsis [34]. The pharmaceuticals to
block IL-8 or enhance PI3K/Akt signaling pathway may
be a promising immunotherapy for antibiotics-resistant
P. aeruginosa, prevention of P. aeruginosa sepsis and
lessen usage of antibiotics.
Abnormalities in the handling of intracellular bacteria
may allow persistent multiplication of bacteria and trigger
chronic uncontrolled intestinal inflammation [35]. A
significant increase in the adaptive immunologic response
to Crohn’s disease (CD)-associated microbial antigens,
such as Pseudomonas fluorescens–related protein (I2) and
Escherichia coli outer membrane porin C (anti-OmpC), is
due to the presence of a defective innate immune gene
(NOD2). HBD-2 is an antimicrobial peptide implicated in
the pathogenesis of inflammatory bowel disease (IBD)
[36]. Children with CD showed a lower expression of
hBD-2 in the inflamed terminal ileum and ascending
colon [37]. It suggests that NOD2 mutants result in
dysregulation of hBD-2 in mucosa intruded by some
Pseudomonas species predisposed to IBD. An inappro-
priate immune response to commensal Pseudomonas
species is involved in colonic CD etiology [38]. NOD1
or NOD2 prevalence in colon or ileum could also be due
to the predominance of different intracellular organisms
or enteroinvasive bacteria for which they are receptors.
Variants of NOD1 and NOD2 genes display opposite asso-
ciations with risk of CD [39]. NOD1 is not involved in
IBD [40] while NOD2 mutants are susceptible to IBD. It is
compatible with the finding that P. aeruginosa was only
identified in the gut of non-IBD patients [38] because the
innate immunity to P. aeruginosa is NOD1-dependent
(Figures 4 and 6) but not NOD2 (data not shown).
NOD1 plays an important role in the initial recognition of
pathogenic bacteria at epithelial surfaces, such as the gut,
where innate immune responses to commensal bacteria
must be avoided [14]. Likewise it was demonstrated that
NOD1 but not NOD2, seems to play a role in chronic
infection of airway by P. aeruginosa in cystic fibrosis
patients [41]. Therefore, it is hypothesized that the loss of
commensal P. aeruginosa in CD patients may result in
dysbiosis between Pseudomonas species and other gut
microbiota, which is directly involved in CD manifestation.
There were many signal pathways reported to be involved
in the regulation of hBD-2 in a variety of cultured cells
infected by P. aeruginosa [33,42,43], including NF-κB,
AP-1, PI3K/Akt, p38MAPK, ERK, and JNK. However
this is the first time to demonstrate the involvement
of NOD1 in P. aeruginosa-induced hBD-2 expression in
intestinal epithelial cells (Figures 4 and 6). Furthermore,
NOD1 expressed by epithelial cells takes part in the activa-
tion of NF-κB and the up-regulated production of an
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to P. aeruginosa [44]. Gram-negative bacteria can deliver
peptidoglycan to cytosolic NOD1 in host cells via a novel
mechanism involving outer membrane vesicles (OMVs)
including the Gram-negative mucosal pathogens [45]:
Helicobacter pylori, Pseudomonas aeruginosa and Neisseria
gonorrhoea. These peptidoglycan-containing OMVs enter
epithelial cells through lipid rafts, thereby upregulating
NF-κB and inducing NOD1-dependent responses in vitro.
Future studies should clarify the role of mucosal NOD1
during P. aeruginosa infection in vivo.
Conclusion
In conclusion, we demonstrated P. aeruginosa induced
proinflammatory responses and antimicrobial peptide in
IECs. Prolonged infection by P. aeruginosa results in
suppression of IL-8 but enhancement of hBD-2 protein
production in SW480 cells, even though both mRNAs
were increased gradually. The PI3K/Akt and ERK signaling
pathway may be involved in the negative regulation of P.
aeruginosa-induced IL-8 production in SW480 cells while
NOD1 protein was involved in the positive regulation of P.
aeruginosa-induced hBD-2 expression.
While antimicrobial peptide in epithelial cells has been
shown to continuously protect the host against prolonged
infection, modulation of proinflammatory responses pro-
tects the host from the detrimental effects of overwhelming
inflammation. The dysbiosis between P. aeruginosa and
other Pseudomonas species or gut microbiota could
be directly involved in the pathogenesis of CD. The
differential regulation of NOD1 and NOD2 in intestinal
mucosa on the commensal and pathogenic bacteria
deserves further investigation.
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Additional files
Additional file 1: Figure S1. The proteins expression of intracellular
signaling pathway in P. aeruginosa-infected Caco-2 cells. Caco-2 cells
were left uninfected (CON), or infected with wild-type P. aeruginosa strain
PAO1 for the indicated times. Activation of the ERK, Akt, p38 and JNK
were analyzed in whole cell protein by immunoblotting with antibodies
to phosphorylated (p) ERK, Akt, p38, and JNK. The results shown are
representative of three separate experiments. GAPDH worked as a
normalization of cytosolic protein.
Additional file 2: Figure S2. The proteins expression of autophagy in
P. aeruginosa-infected Caco-2 cells. Caco-2 cells were uninfected (CON) or
infected by wild-type P. aeruginosa strain PAO1 for the indicated times.
The Western blots illustrate the expression of Agt5, Beclin 1, and NOD1
proteins in cytosolic extracts of Caco-2 cells. The results shown are repre-
sentative of three separate experiments. GAPDH worked as a
normalization of cytosolic protein.
Additional file 3: Figure S3. Involvement of ERK and PI3K/Akt signal
pathways in P. aeruginosa-induced IL-8 and hBD-2 in Caco-2 cells. Effectof ERK and PI3K inhibition on P. aeruginosa-induced IL-8 and hBD-2 secre-
tion. Caco-2 cells were left untreated, or treated with 25 μM PD98059
(PD) and 50 μM LY294002 (LY) for one hour. They were then infected
with the wild-type P. aeruginosa strain PAO1. Supernatant was analyzed
by ELISA for IL-8 and hBD-2. The amount of IL-8 or hBD-2 produced is
shown as the fold increase over control cells (CON). Results are repre-
sented as means ±S.E.M. for at least three determinations from independ-
ent experiments. (* p < 0.05; # p < 0.05).
Additional file 4: Figure S4. Involvement of NOD1 in P.
aeruginosa-induced IL-8 and hBD-2 in Caco-2 cells. Caco-2 cells were
transfected with control siRNA and NOD1 siRNA (siRNA = non-target
control siRNA; siNod1 = siRNA to NOD1) for 48 hours. The transfected
cells were left uninfected or infected by wild-type P. aeruginosa strain
PAO1. Supernatant was analyzed by ELISA for secreted IL-8 and hBD-2
protein in Caco-2 cells. The amount of IL-8 or hBD-2 produced is shown
as the fold increase over control cells (CON). Results are represented as
means ±S.E.M. for at least three determinations from independent experiments.
An asterisk indicates a significant difference (* p < 0.05).
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